Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta
- PMID: 20188343
- PMCID: PMC2833387
- DOI: 10.1016/j.ajhg.2010.01.034
Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta
Abstract
Osteogenesis imperfecta (OI) is characterized by bone fragility and fractures that may be accompanied by bone deformity, dentinogenesis imperfecta, short stature, and shortened life span. About 90% of individuals with OI have dominant mutations in the type I collagen genes COL1A1 and COL1A2. Recessive forms of OI resulting from mutations in collagen-modifying enzymes and chaperones CRTAP, LEPRE1, PPIB, and FKBP10 have recently been identified. We have identified an autosomal-recessive missense mutation (c.233T>C, p.Leu78Pro) in SERPINH1, which encodes the collagen chaperone-like protein HSP47, that leads to a severe OI phenotype. The mutation results in degradation of the endoplasmic reticulum resident HSP47 via the proteasome. Type I procollagen accumulates in the Golgi of fibroblasts from the affected individual and a population of the secreted type I procollagen is protease sensitive. These findings suggest that HSP47 monitors the integrity of the triple helix of type I procollagen at the ER/cis-Golgi boundary and, when absent, the rate of transit from the ER to the Golgi is increased and helical structure is compromised. The normal 3-hydroxylation of the prolyl residue at position 986 of the triple helical domain of proalpha1(I) chains places the role of HSP47 downstream from the CRTAP/P3H1/CyPB complex that is involved in prolyl 3-hydroxylation. Identification of this mutation in SERPINH1 gives further insight into critical steps of the collagen biosynthetic pathway and the molecular pathogenesis of OI.
Copyright 2010 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes.Hum Mol Genet. 2011 Apr 15;20(8):1595-609. doi: 10.1093/hmg/ddr037. Epub 2011 Jan 31. Hum Mol Genet. 2011. PMID: 21282188 Free PMC article.
-
Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome.J Bone Miner Res. 2011 Mar;26(3):666-72. doi: 10.1002/jbmr.250. J Bone Miner Res. 2011. PMID: 20839288 Free PMC article.
-
Interaction between KDELR2 and HSP47 as a Key Determinant in Osteogenesis Imperfecta Caused by Bi-allelic Variants in KDELR2.Am J Hum Genet. 2020 Nov 5;107(5):989-999. doi: 10.1016/j.ajhg.2020.09.009. Epub 2020 Oct 13. Am J Hum Genet. 2020. PMID: 33053334 Free PMC article.
-
Bone collagen: new clues to its mineralization mechanism from recessive osteogenesis imperfecta.Calcif Tissue Int. 2013 Oct;93(4):338-47. doi: 10.1007/s00223-013-9723-9. Epub 2013 Mar 19. Calcif Tissue Int. 2013. PMID: 23508630 Free PMC article. Review.
-
Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta.Cell Tissue Res. 2010 Jan;339(1):59-70. doi: 10.1007/s00441-009-0872-0. Epub 2009 Oct 28. Cell Tissue Res. 2010. PMID: 19862557 Free PMC article. Review.
Cited by
-
HSP47 in human diseases: Navigating pathophysiology, diagnosis and therapy.Clin Transl Med. 2024 Aug;14(8):e1755. doi: 10.1002/ctm2.1755. Clin Transl Med. 2024. PMID: 39135385 Free PMC article. Review.
-
Update on the Genetics of Osteogenesis Imperfecta.Calcif Tissue Int. 2024 Aug 11. doi: 10.1007/s00223-024-01266-5. Online ahead of print. Calcif Tissue Int. 2024. PMID: 39127989 Review.
-
Osteogenesis imperfecta type 10 and the cellular scaffolds underlying common immunological diseases.Genes Immun. 2024 Aug;25(4):265-276. doi: 10.1038/s41435-024-00277-4. Epub 2024 May 29. Genes Immun. 2024. PMID: 38811682 Review.
-
IFITM5-related (type V) osteogenesis imperfecta with evidence of perinatal involvement: A case report.Bone Rep. 2024 Apr 17;21:101766. doi: 10.1016/j.bonr.2024.101766. eCollection 2024 Jun. Bone Rep. 2024. PMID: 38681748 Free PMC article.
-
SERPINC1 c.1247dupC: a novel SERPINC1 gene mutation associated with familial thrombosis results in a secretion defect and quantitative antithrombin deficiency.Thromb J. 2024 Feb 12;22(1):19. doi: 10.1186/s12959-024-00589-5. Thromb J. 2024. PMID: 38347553 Free PMC article.
References
-
- Byers P.H., Cole W.G. Osteogenesis imperfecta. In: Royce P.M., Steinmann B., editors. Connective Tissue and It's Heritable Disorders: Molecular, Genetic, and Medical Aspects. Wiley-Liss, Inc.; New York: 2002. pp. 385–430.
-
- Rauch F., Glorieux F.H. Osteogenesis imperfecta. Lancet. 2004;363:1377–1385. - PubMed
-
- Marini J.C., Forlino A., Cabral W.A., Barnes A.M., San Antonio J.D., Milgrom S., Hyland J.C., Körkkö J., Prockop D.J., De Paepe A. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: Regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum. Mutat. 2007;28:209–221. - PMC - PubMed
-
- Morello R., Bertin T.K., Chen Y., Hicks J., Tonachini L., Monticone M., Castagnola P., Rauch F., Glorieux F.H., Vranka J. CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell. 2006;127:291–304. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous
